Purity | Size | Price | VIP Price | USA Stock *0-1 Day | Global Stock *5-7 Days | Quantity | |||||
{[ item.p_purity ]} | {[ item.pr_size ]} |
{[ getRatePrice(item.pr_usd, 1,1) ]} {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate) ]} |
{[ getRatePrice(item.pr_usd, 1,1) ]} | Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate) ]} {[ getRatePrice(item.pr_usd,1,item.mem_rate) ]} | {[ item.pr_usastock ]} | Inquiry - | {[ item.pr_chinastock ]} | Inquiry - |
* Storage: {[proInfo.prStorage]}
CAS No. : | 14825-82-2 | MDL No. : | MFCD03411306 |
Formula : | C10H9NO3 | Boiling Point : | - |
Linear Structure Formula : | - | InChI Key : | GQBIVYSGPXCELZ-QMMMGPOBSA-N |
M.W : | 191.18 | Pubchem ID : | 13517184 |
Synonyms : |
|
Num. heavy atoms : | 14 |
Num. arom. heavy atoms : | 6 |
Fraction Csp3 : | 0.2 |
Num. rotatable bonds : | 2 |
Num. H-bond acceptors : | 3.0 |
Num. H-bond donors : | 1.0 |
Molar Refractivity : | 52.31 |
TPSA : | 55.4 Ų |
GI absorption : | High |
BBB permeant : | No |
P-gp substrate : | No |
CYP1A2 inhibitor : | No |
CYP2C19 inhibitor : | No |
CYP2C9 inhibitor : | No |
CYP2D6 inhibitor : | No |
CYP3A4 inhibitor : | No |
Log Kp (skin permeation) : | -6.39 cm/s |
Log Po/w (iLOGP) : | 1.42 |
Log Po/w (XLOGP3) : | 1.52 |
Log Po/w (WLOGP) : | 0.48 |
Log Po/w (MLOGP) : | 1.29 |
Log Po/w (SILICOS-IT) : | 1.56 |
Consensus Log Po/w : | 1.26 |
Lipinski : | 0.0 |
Ghose : | None |
Veber : | 0.0 |
Egan : | 0.0 |
Muegge : | 1.0 |
Bioavailability Score : | 0.55 |
Log S (ESOL) : | -2.17 |
Solubility : | 1.3 mg/ml ; 0.00679 mol/l |
Class : | Soluble |
Log S (Ali) : | -2.29 |
Solubility : | 0.976 mg/ml ; 0.00511 mol/l |
Class : | Soluble |
Log S (SILICOS-IT) : | -2.97 |
Solubility : | 0.203 mg/ml ; 0.00106 mol/l |
Class : | Soluble |
PAINS : | 0.0 alert |
Brenk : | 2.0 alert |
Leadlikeness : | 1.0 |
Synthetic accessibility : | 2.24 |
Signal Word: | Warning | Class: | N/A |
Precautionary Statements: | P261-P305+P351+P338 | UN#: | N/A |
Hazard Statements: | H302-H315-H319-H335 | Packing Group: | N/A |
GHS Pictogram: |
* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
94% | at 50℃; | 2.3 Preparation of l-phenylalanine N-carboxyanhydride (NCA) (Scheme 2) A 1 L round bottom was dried in an oven prior to use (oven temp = 120 °C). The glassware was cooled under an inert nitrogen atmosphere. Phenylalanine (50.0 g, 303 mmol) was added to the flask. Anhydrous THF (600 mL, 0.5 M) was charged to give a suspension of white solid. The mixture was heated to 50 °C and triphosgene (35.9 g, 121 mmol, 0.4 equivalents) was added as a solid. The suspension was stirred until the reaction was clear (∼30 min). The reaction mixture was cooled to ambient temperature then concentrated to an oil. The oil was then slowly poured into 3 L of hexanes with rapid stirring to yield a white precipitate. The resulting suspension was capped using aluminum foil and placed in the freezer for 3 h. The white precipitate was then filtered via vacuum filtration while maintaining an inert environment. The white solid was rinsed with hexanes (3 * 20 mL) to give the product. The white solid was collected and dried overnight under vacuum. GC/MS was used to confirm the product (54.0 g, 94percent yield). 1H NMR (500 MHz, CHCl3-d): δ 7.37 - 7.30 (3 H, m); 7.18 (2 H, d, J = 7.21 Hz); 6.23 (1 H, s); 4.53 (1 H, dd, J = 8.18, 4.21 Hz); 3.27 (1 H, dd, J = 14.14, 4.20 Hz); 3.00 (1 H, dd, J = 14.13, 8.17 Hz) . |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
86% | at 50℃; for 1 h; | Phenylalanine NCA [0393] H-L-Phe-OH (20.0 g, 132 mmol) was suspended in 300 mL of anhydrous THF and heated to 50° C. Phosgene (20percent in toluene) (90 mL, 182 mmol) was added to the amino acid suspension, and the amino acid dissolved over the course of approx. 1 hr, forming a cloudy solution. The solution was filtered through a paper filter (Whatman 1), concentrated on by rotary evaporation, transferred to a beaker, and hexane was added to precipitate the product. The white solid was isolated by filtration and dissolved in anhydrous THF. The solution was filtered over a bed of Celite to remove any insoluble material. An excess of hexanes were added on the filtrate while stirring with a spatula. The NCA was isolated by filtration and dried in vacuo. 20.0 g (86percent yield) of D-PheNCA was isolated as a white, crystalline solid. 1H NMR (d6-DMSO) δ 9.09 (1H), 7.40-7.08 (5H), 4.788 (1H), 3.036 (2H) ppm. |
86% | at 50℃; for 1.5 h; | H-E-Phe-OH (20.0 g, 132 mmol) was suspended in300 mE of anhydrous THF and heated to 50° C. Phosgene (20percent in toluene) (90 mE, 182 mmol) was added to the amino acid suspension, and the amino acid dissolved over the course of approx. 1 hr, forming a cloudy solution. The solution was filtered through a paper filter (Whatman 1), concentrated on by rotary evaporation, transferred to a beaker, and hexane was added to precipitate the product. The white solid was isolated by filtration and dissolved in anhydrous THF. The solution was filtered over a bed of Celite to remove any insoluble material. An excess of hexanes were added on the filtrate while stirring with a spatula. The NCA was isolated by filtration and dried invacuo. 20.0 g (86percent yield) of D-PheNCA wasisolated as a white, crystalline solid. ‘H NMR (d5-DMSO)9.09 (1H), 7.40-7.08 (5H), 4.788 (1H), 3.036 (2H) ppm. |
[ 3415-08-5 ]
(S)-4-(4-Hydroxybenzyl)oxazolidine-2,5-dione
Similarity: 0.93
[ 19887-32-2 ]
(S)-2-((Ethoxycarbonyl)amino)-3-phenylpropanoic acid
Similarity: 0.92
[ 51987-73-6 ]
Methyl (tert-butoxycarbonyl)-L-phenylalaninate
Similarity: 0.91
[ 77119-84-7 ]
(R)-Methyl 2-((tert-butoxycarbonyl)amino)-3-phenylpropanoate
Similarity: 0.91